WebAug 8, 2024 · Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious … WebJul 6, 2024 · Reportedly, Atossa Therapeutics has received approval from the Swedish Medical Product Agency to initiate a Phase 2 clinical study of oral Endoxifen for the reduction of mammographic breast ...
Why Atossa Therapeutics Stock Is Tumbling Today
WebApr 7, 2024 · Atossa Therapeutics has such a small amount of debt that we'll set it aside, and focus on the US$40m in cash it held at December 2024. Looking at the last year, the company burnt through US$12m ... WebJun 28, 2024 · Atossa Therapeutics ( ATOS 1.57%) has been a top-performing biotech stock rising more than this year. Successful results from a mid-stage clinical trial with a … college of arts and science fsu
Atossa Therapeutics Announces Final Data from Phase 2
WebView the latest top stories from CNN Money Visit CNNMoney.com for daily and breaking news from the world of business. ... No recent news for Atossa Therapeutics Inc. Today’s Trading. Previous close: 0.87: Today’s open: 0.88: Day’s range: 0.83 - 0.88: Volume: 18,197: Average volume (3 months) 1,116,125: Market cap: WebAtossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the ... WebJun 9, 2024 · Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on ... dr posner boca raton fl